SCHEMBL6860632

SCHEMBL6860632

CC(C)(C)OC(=O)C1(C(=O)O)CC(O)CN1

nearest known ligand 0.33

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
ARG1 P05089 2/20 0.33
ARG2 P78540 2/20 0.33
CHRM2 P08172 1/20 0.32
CHRM1 P11229 1/20 0.32
CHRM3 P20309 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10519878 1.00 ARG1 (0.33) ARG1ARG2CHRM2CHRM1CHRM3
SCHEMBL16759533 0.86 CHRM2 (0.31) CHRM2CHRM1CHRM3
SCHEMBL16759581 0.86 CHRM2 (0.31) CHRM2CHRM1CHRM3
SCHEMBL16759709 0.86 CHRM2 (0.31) CHRM2CHRM1CHRM3
SCHEMBL10669809 0.84
SCHEMBL28476403 0.84
SCHEMBL7286719 0.78 ARG1 (0.42) ARG1ARG2
SCHEMBL6422818 0.76
SCHEMBL29548435 0.76 CTSK (0.34)
SCHEMBL221457 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6800434-B2 Peptides as NS3-serine protease inhibitors of hepatitis C virus SCHERING CORPORATION 2004-10-05 US disclosed